Literature DB >> 23998048

The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions.

Rakhee Yadav1, Jai Prakash Bhartiya, Sunil Kumar Verma, Manoj Kumar Nandkeoliar.   

Abstract

BACKGROUND: Diabetes mellitus is a chronic metabolic disorder which is associated with hyperglycaemia. It is caused by a derangement in the secretion or function of the endocrinal portion of the pancreas. There is a close anatomical and functional relationship between its exocrine and endocrine portions. To address this issue, the current study was designed to evaluate the blood glucose and the amylase levels of diabetic patients as representatives of the two portions of the pancreas respectively. AIMS AND
OBJECTIVES: The aim of the present study was to determine the blood glucose, serum amylase and the serum lipid profile in known cases of type 2 Diabetes Mellitus and to compare and correlate these parameters with those of age and sex matched healthy controls.
MATERIAL AND METHODS: One hundred ten patients of type 2 Diabetes mellitus, who were already diagnosed and were taking treatment, were included in this study. 30 age and sex matched healthy individuals were recruited as the control group in our study. Fasting venous blood samples were collected from the patients as well as the controls and they were analysed by using an automated analyser for blood glucose, serum amylase and the lipid profile (serum triglycerides, total cholesterol, high density lipoproteins and low density lipoproteins). The results were analyzed statistically by using the Student's "t" test and correlation coefficients.
RESULTS: Significantly low serum amylase levels were found in the diabetic patients as compared to those in the healthy controls (p value <0.001). Also, the levels of fasting serum total cholesterol, triglycerides and the low density lipoproteins were significantly higher in the patients as compared to those in the controls, with p values of <0.05, <0.001 and <0.001 respectively. The HDL (high density lipoprotein) level was found to be lower in the diabetic patients (p value <0.001).
CONCLUSIONS: From our study, it was concluded that in type 2 Diabetes mellitus, wherever the blood glucose level was higher, the serum amylase activity was found to be significantly lower. This reflected the derangement in the endocrine-exocrine axis of the pancreas, as a disease which affected any portion of an organ would affect the adjoining area of that organ functionally. This fact must be kept in mind while the patients are treated.

Entities:  

Keywords:  Amylase; Diabetes mellitus; Lipid profile; Pancreatic functions

Year:  2013        PMID: 23998048      PMCID: PMC3749618          DOI: 10.7860/JCDR/2013/6016.3120

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  24 in total

1.  Flare-up of serum amylase prior to onset of lethal ketoacidosis in a patient with fulminant type 1 diabetes.

Authors:  Jin Takahashi; Koji Nishijima; Ken-Ichi Shukunami; Akira Yakihara; Toru Senda; Yoshio Yoshida; Fumikazu Kotsuji
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

Review 2.  The role of gut hormones in glucose homeostasis.

Authors:  Daniel J Drucker
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Islet growth factors: curing diabetes and preventing chronic pancreatitis?

Authors:  M Korc
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

4.  Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes.

Authors:  M C Vantyghem; S Haye; M Balduyck; C Hober; P M Degand; J Lefebvre
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

5.  Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  T Kobayashi; K Nakanishi; H Kajio; S Morinaga; T Sugimoto; T Murase; K Kosaka
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

6.  Hyperamylasemia in diabetic ketoacidosis: sources and significance.

Authors:  F Vinicor; L M Lehrner; R C Karn; A D Merritt
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

7.  A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM.

Authors:  A K Foulis; M McGill; M A Farquharson; D A Hilton
Journal:  Diabetologia       Date:  1997-01       Impact factor: 10.122

8.  Molecular investigation of age-related changes in mouse endocrine pancreas.

Authors:  R Perfetti; Y Wang; A R Shuldiner; J M Egan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-09       Impact factor: 6.053

9.  TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes.

Authors:  F Sanvito; A Nichols; P L Herrera; J Huarte; A Wohlwend; J D Vassalli; L Orci
Journal:  Biochem Biophys Res Commun       Date:  1995-12-26       Impact factor: 3.575

10.  Increased somatostatin content of islets from streptozotocin-diabetic rats.

Authors:  Y C Patel; G C Weir
Journal:  Clin Endocrinol (Oxf)       Date:  1976-03       Impact factor: 3.478

View more
  9 in total

1.  Pancreatic α-Amylase Controls Glucose Assimilation by Duodenal Retrieval through N-Glycan-specific Binding, Endocytosis, and Degradation.

Authors:  Kimie Date; Ayano Satoh; Kaoruko Iida; Haruko Ogawa
Journal:  J Biol Chem       Date:  2015-05-28       Impact factor: 5.157

2.  Evaluation of Biochemical Markers Serum Amylase and Serum Lipase for the Assessment of Pancreatic Exocrine Function in Diabetes Mellitus.

Authors:  Mahesh Basavaraj Madole; Chandrashekhar M Iyer; Mamatha Thimmanna Madivalar; Satish Kishanrao Wadde; Deepak Sadashiv Howale
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  Estimation of Salivary and Serum Biomarkers in Diabetic and Non Diabetic Patients - A Comparative Study.

Authors:  Amit Ladgotra; Pradhuman Verma; Seetharamaiah Sunder Raj
Journal:  J Clin Diagn Res       Date:  2016-06-01

4.  Correlation between blood lipid levels and chronic pancreatitis: a retrospective case-control study of 48 cases.

Authors:  Qingqiang Ni; Lin Yun; Rui Xu; Dong Shang
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats.

Authors:  Shadae R Foster; Lowell L Dilworth; Jean Sparks; Ruby L Alexander-Lindo; Felix O Omoruyi
Journal:  Adv Pharmacol Sci       Date:  2019-10-15

6.  A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.

Authors:  Ryosuke Desaki; Shugo Mizuno; Akihiro Tanemura; Masashi Kishiwada; Yasuhiro Murata; Yoshinori Azumi; Naohisa Kuriyama; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Shuji Isaji
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

Review 7.  New Frontiers for the Use of IP6 and Inositol Combination in Treating Diabetes Mellitus: A Review.

Authors:  Felix O Omoruyi; Dewayne Stennett; Shadae Foster; Lowell Dilworth
Journal:  Molecules       Date:  2020-04-10       Impact factor: 4.411

8.  Clinical Characteristics of Concomitant Diabetic Ketoacidosis in Type 2 Diabetes Patients with Acute Pancreatitis.

Authors:  Yan Fu; Xue Liu; Beichen Cui; Cong Wang; Zhiwei Liu; Bin Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-11       Impact factor: 3.168

9.  Exocrine pancreas proteases regulate β-cell proliferation in zebrafish ciliopathy models and in murine systems.

Authors:  Timothy L Hostelley; Jessica E Nesmith; Emily Larkin; Amanda Jones; Daniel Boyes; Carmen C Leitch; Magali Fontaine; Norann A Zaghloul
Journal:  Biol Open       Date:  2021-06-14       Impact factor: 2.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.